INPP5B and oculocerebrorenal syndrome: Collectively, these data illustrate the possibility that OCRL-related disorders could be rescued by increasing levels of INPP5B, perhaps via AAV gene delivery or via drugs known to upregulate INPP5B expression in Lowe syndrome-affected tissues.